Drug-induced enterocolitis syndrome: Similarities and differences compared with food protein-induced enterocolitis syndrome

23Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In 2014, drug-induced enterocolitis syndrome (DIES) was described for the first time. It is still a poorly known disease with symptoms that typically resemble those of food protein–induced enterocolitis syndrome (FPIES). To date, six more cases of DIES have been described and new clinical diagnostic criteria have been proposed based on those in the international guidelines for FPIES. In this paper, the authors describe three more cases of DIES. In addition, similarities and differences with FPIES have been deeply analyzed. To date, several unanswered questions need to be addressed, but clinicians must be instructed how to identify DIES, in order to make an allergy workup and give definite therapeutic indications to patients, especially in children where DIES seems to be more frequent.

Cite

CITATION STYLE

APA

Mori, F., Liccioli, G., Fuchs, O., Barni, S., Giovannini, M., Sarti, L., … Caubet, J. C. (2021). Drug-induced enterocolitis syndrome: Similarities and differences compared with food protein-induced enterocolitis syndrome. Pediatric Allergy and Immunology, 32(6), 1165–1172. https://doi.org/10.1111/pai.13491

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free